Aqua Bio Technology ASA (ABT.OL)
NOK 6.93
(0.0%)
NOK 6.93
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2021 | 607.92 Thousand NOK | 213.18% |
| 2020 | -537.11 Thousand NOK | -1.42% |
| 2019 | -529.58 Thousand NOK | 58.22% |
| 2018 | -1.26 Million NOK | -811.41% |
| 2017 | -139.07 Thousand NOK | 0.0% |
| 2016 | - NOK | -100.0% |
| 2015 | 305.88 Thousand NOK | -46.57% |
| 2014 | 572.51 Thousand NOK | -86.11% |
| 2013 | 4.12 Million NOK | 223.48% |
| 2012 | 1.27 Million NOK | 752.11% |
| 2011 | 149.53 Thousand NOK | 143.52% |
| 2010 | 61.4 Thousand NOK | 0.0% |
| 2009 | - NOK | -100.0% |
| 2008 | 87.45 Thousand NOK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2021 FY | 607.92 Thousand NOK | 213.18% |
| 2020 FY | -537.11 Thousand NOK | -1.42% |
| 2019 FY | -529.58 Thousand NOK | 58.22% |
| 2018 FY | -1.26 Million NOK | -811.41% |
| 2017 FY | -139.07 Thousand NOK | 0.0% |
| 2016 FY | - NOK | -100.0% |
| 2016 Q1 | - NOK | -100.0% |
| 2016 Q2 | - NOK | 0.0% |
| 2016 Q3 | - NOK | 0.0% |
| 2016 Q4 | - NOK | 0.0% |
| 2015 FY | 305.88 Thousand NOK | -46.57% |
| 2015 Q3 | 117.28 Thousand NOK | 0.0% |
| 2015 Q4 | 64.09 Thousand NOK | -45.35% |
| 2015 Q1 | 124.5 Thousand NOK | 119.94% |
| 2015 Q2 | - NOK | -100.0% |
| 2014 Q3 | 485.59 Thousand NOK | 82.29% |
| 2014 Q1 | 444.97 Thousand NOK | 40.75% |
| 2014 Q2 | 266.38 Thousand NOK | -40.14% |
| 2014 FY | 572.51 Thousand NOK | -86.11% |
| 2014 Q4 | -624.43 Thousand NOK | -228.59% |
| 2013 FY | 4.12 Million NOK | 223.48% |
| 2013 Q4 | 316.13 Thousand NOK | 34.08% |
| 2013 Q3 | 235.78 Thousand NOK | -92.19% |
| 2013 Q2 | 3.02 Million NOK | 616.45% |
| 2013 Q1 | 421.54 Thousand NOK | 5.32% |
| 2012 Q1 | 11.74 Million NOK | 22370.43% |
| 2012 FY | 1.27 Million NOK | 752.11% |
| 2012 Q4 | 400.24 Thousand NOK | 274.57% |
| 2012 Q3 | 106.85 Thousand NOK | 125.68% |
| 2012 Q2 | 47.34 Thousand NOK | -99.6% |
| 2011 Q1 | 2173.00 NOK | -96.46% |
| 2011 Q4 | 52.25 Thousand NOK | 143.07% |
| 2011 FY | 149.53 Thousand NOK | 143.52% |
| 2011 Q3 | 21.5 Thousand NOK | -93.76% |
| 2011 Q2 | 344.6 Thousand NOK | 15758.26% |
| 2010 Q2 | - NOK | 0.0% |
| 2010 FY | 61.4 Thousand NOK | 0.0% |
| 2010 Q4 | 61.4 Thousand NOK | 0.0% |
| 2010 Q1 | - NOK | 0.0% |
| 2010 Q3 | - NOK | 0.0% |
| 2009 FY | - NOK | -100.0% |
| 2008 FY | 87.45 Thousand NOK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Arctic Bioscience AS | 9.77 Million NOK | 93.78% |
| ArcticZymes Technologies ASA | 113.01 Million NOK | 99.462% |
| BerGenBio ASA | 354 Thousand NOK | -71.731% |
| Hofseth BioCare ASA | 29.87 Million NOK | 97.965% |
| PCI Biotech Holding ASA | 2.99 Million NOK | 79.668% |
| Thor Medical ASA | - NOK | -Infinity% |
| Ultimovacs ASA | -2.76 Million NOK | 121.963% |